Clinical Trials Directory

Trials / Unknown

UnknownNCT03431454

Comparison of Three Vision Therapy Approaches for Convergence Insufficiency

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
Shahid Beheshti University of Medical Sciences · Academic / Other
Sex
All
Age
15 Years – 35 Years
Healthy volunteers
Accepted

Summary

We compared the effectiveness of three active vision therapy approaches for convergence insufficiency (CI). Patients with eligible criteria and symptomatic CI were included in a prospective study and randomly allocated into three groups. In the home-based vision orthoptic therapy (HBVOT) group, patients were trained to do the pencil push-ups procedure 15 minutes per day, five days a week. In the office-based vision orthoptic therapy (OBVOT) group, 60 minutes of orthoptic therapy using a major amblyoscope twice weekly with additional home orthoptic therapy was prescribed. For the augmented office-based vision orthoptic therapy (AOBVOT) group, orthoptic exercises using three diopter over-minus lenses and a base out prism, in addition to major amblyoscope and additional home reinforcement was prescribed in the same period of time.

Conditions

Interventions

TypeNameDescription
PROCEDUREtrained to do the pencil push-ups procedure15 minutes per day, five days a week
PROCEDUREusing a major amblyoscope twice weekly with additional home orthoptic therapy60 minutes of orthoptic therapy using a major amblyoscope twice weekly with additional home orthoptic therapy was prescribed.
PROCEDUREusing three diopter over-minus lenses and a base out prismFor the augmented office-based vision orthoptic therapy (AOBVOT) group, orthoptic exercises using three diopter over-minus lenses and a base out prism, in addition to major amblyoscope and additional home reinforcement was prescribed in the same period of time.

Timeline

Start date
2018-02-01
Primary completion
2018-07-01
Completion
2018-12-01
First posted
2018-02-13
Last updated
2018-02-13

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT03431454. Inclusion in this directory is not an endorsement.